Pharmaceutical and biotech companies are expanding their research pipelines to address unmet medical needs, leading to a surge in clinical trial activities
DOI: 10.1073/pnas.0406491101 Epub 2004 Sep 29 21
Added BPC-157 300mcg daily
The total addressable market for diabetes and weight loss in just the United States is quite large: Approximately 9% of the US population (~29M) has diabetes, including ~28M diagnosed with Type 2 Diabetes (T2D)
Research shows BPC-157 treatment accelerates healing of transected tendons through promotion of tendon outgrowth, cell survival, and cell migration via regulation of ERK1/2 phosphorylation and downstream targets including c-Fos, c-Jun, and Egr-1key molecules involved in cell growth, migration, and angiogenesis
Studies show that lysine with L-arginine makes bone building cells more active and enhances production of collagen